A comprehensive view of prescription drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Patent Issued for Metabolites of GLP1R agonists (USPTO 12065434)
Published:
September 06, 2024
by Heart Disease Daily
|
NY A10193: Expands state definition to include all FDA approved forms and doses of Naloxone as opioid antagonists with health department approval.
Published:
September 06, 2024
by New York 2023-2024 General Assembly
|
US HB7347: Requires Veterans Affairs Secretary to report on including psychedelic drugs in the department's formulary.
Published:
September 06, 2024
by US Congress 118th Congress
|
MA H1155: Establishes responsibilities and duties for pharmacy benefit managers, including negotiating drug prices and managing prescription drug benefits.
Published:
September 05, 2024
by Massachusetts 193rd General Court
|
MA H1142: Eliminates cost-sharing for naloxone and other opioid antagonists in health insurance plans.
Published:
September 05, 2024
by Massachusetts 193rd General Court
|
Ask us about our Health Care Sector market view